Combined, the results demonstrate a facile approach that supports a more complete 40
INTRODUCTION

45
Acinetobacter baumannii has become a significant concern in hospital settings due to its ability 46 to survive under a wide range of environmental conditions, persist for extended periods on 47 fomites, and perhaps most importantly, develop or acquire myriad mechanisms to counter a 48 variety of antimicrobial compounds (1-5). In particular, the high rates of antimicrobial resistance 49 among nosocomial isolates and its rising prevalence among hospital-acquired infections have 50 made A. baumannii a significant source of morbidity, mortality, and economic loss (6-11). This 51 opportunistic pathogen has been an especially serious threat for personnel hospitalized in 
RESULTS
158
Phenotypic resistance overview. Of the 97 A. baumannii clinical isolates that were selected for 159 this study, 78 (80%) were resistant to three or more classes of antimicrobial compounds and thus 160 considered MDR (Table 1 ). In contrast, eight strains were considered pan-susceptible, with no that did not harbor any of these genes (Tables 1 and 2 ). The phenotypic tetracycline resistance of 288 these latter samples also cannot be explained by Ade efflux pumps as recently reported (42, 43),
289
and there must be another undefined resistance mechanism at play here.
291
Thirty of the isolates were tested for the presence or absence of the tet(39), tet(A) and tet(B) Of the 97 isolates tested on the ARDM, 45% were shown to contain both qacEΔ1 and sulI genes 326 ( carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone. J. Clin. 
blaOXA-51-like, blaOXA-58- 
